Two Sigma Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.7M | Buy |
|
|||||
|
2025
Q1 | $45M | Sell |
|
|||||
|
2024
Q4 | $105M | Sell |
|
|||||
|
2024
Q3 | $494M | Sell |
|
|||||
|
2024
Q2 | $472M | Buy |
|
|||||
|
2024
Q1 | $485M | Buy |
|
|||||
|
2023
Q4 | $457M | Buy |
|
|||||
|
2023
Q3 | $384M | Buy |
|
|||||
|
2023
Q2 | $120M | Buy |
|
|||||
|
2023
Q1 | $27.5M | Sell |
|
|||||
|
2022
Q4 | $29.2M | Sell |
|
|||||
|
2022
Q3 | $217M | Sell |
|
|||||
|
2022
Q2 | $363M | Buy |
|
|||||
|
2022
Q1 | $318M | Sell |
|
|||||
|
2021
Q4 | $413M | Buy |
|
|||||
|
2021
Q3 | $391M | Buy |
|
|||||
|
2021
Q2 | $54.5M | Buy |
|
|||||
|
2021
Q1 | $1.22M | Sell |
|
|||||
|
2020
Q4 | $80.1M | Sell |
|
|||||
|
2020
Q3 | $315M | Buy |
|
|||||
|
2020
Q2 | $222M | Buy |
|
|||||
|
2020
Q1 | $65.8M | Sell |
|
|||||
|
2019
Q4 | $417M | Sell |
|
|||||
|
2019
Q3 | $440M | Buy |
|
|||||
|
2019
Q2 | $389M | Buy |
|
|||||
|
2019
Q1 | $385M | Buy |
|
|||||
|
2018
Q4 | $145M | Buy |
|
|||||
|
2018
Q3 | $88.1M | Sell |
|
|||||
|
2018
Q2 | $85M | Sell |
|
|||||
|
2018
Q1 | $115M | Sell |
|
|||||
|
2017
Q4 | $180M | Sell |
|
|||||
|
2017
Q3 | $266M | Buy |
|
|||||
|
2017
Q2 | $143M | Sell |
|
|||||
|
2017
Q1 | $166M | Buy |
|
|||||
|
2016
Q4 | $7.27M | Sell |
|
|||||
|
2016
Q3 | $62.1M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $947K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $933K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $2.71M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.13M | Sell |
|
|||||
|
2013
Q3 | $2.6M | Buy |
|
|||||
|
2013
Q2 | – | Hold |
|